Login Register Cart 0
Generic placeholder image

Current Analytical Chemistry

Editor-in-Chief

ISSN (Print): 1573-4110
ISSN (Online): 1875-6727

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Enantioselective Analysis of Mexiletine Using Chromatographic Techniques: A Review

Author(s): Vinod Kumar Vashistha*

Volume 18, Issue 4, 2022

Published on: 08 October, 2020

Page: [440 - 455] Pages: 16

DOI: 10.2174/1573411016999201008125143

Price: $65

Abstract

Background: Mexiletine belongs to the β-amino-aryl-ether group of pharmaceutical and applied in the diagnosis of antiarrhythmics, allodynia, and myotonic disorders. In its chemical structure, it possesses a chiral center and practiced in the form of the racemic mixture. The production and accessibility of mexiletine have accompanied with a meaningful development in awareness of its pharmacologic actions. But in clinical arrhythmias and binding experiments on cardiac sodium channels, the (R)-enantiomer of mexiletine is more potent than the (S)-enantiomer. Also, (S)-enantiomer is further active in the diagnosis of allodynia than the (R)-enantiomer

Methods: During the last two decades, chromatographic techniques such as HPLC, and GC coupled with mass spectrometry or field ionization detector have been used for the stereoselective analysis of MEX enantiomers

Results: The direct enantioresolution deals with the use of chiral stationary phases (CSPs) with or no pre-derivatization which depend on a chromophoric entity in the racemates whereas the indirect HPLC process involves the use of chiral derivatization reagents (CDR) for the synthesis of diastereomeric derivatives of racemates. Different techniques have their strengths and weaknesses.

Conclusion: Regulation of enantiomeric purity and estimation of particular enantiomers of drug molecules stay an essential topic for therapeutic, diagnostic, and regulatory uses and to promote a precise assessment of the hazards to human health by false enantiomers. This review aims to offer a systematic survey of the analytical methods (chromatography based) used in the enantioselective analysis of MEX developed in the last two decades (the year 2000 onwards).

Keywords: Mexiletine, HPLC, GC, TLC, direct separation, indirect separation, enantioselective analysis

« Previous Next »
Graphical Abstract

[1]
Calcaterra, A.; D’Acquarica, I. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds. J. Pharm. Biomed. Anal., 2018, 147, 323-340.
[http://dx.doi.org/10.1016/j.jpba.2017.07.008] [PMID: 28942107]
[2]
Kleemann, A. Pharmaceutical substances: Syntheses, patents, applications. Thieme. Medical. Pub, 2001, 2001, 1.
[3]
Carocci, A.; Catalano, A.; Corbo, F.; Duranti, A.; Amoroso, R.; Franchini, C.; Lentini, G.; Tortorella, V. Stereospecific synthesis of MEXiletine and related compounds: Mitsunobu versus Williamson reaction. Tetrahedron Asymmetry, 2000, 11(17), 3619-3634.
[http://dx.doi.org/10.1016/S0957-4166(00)00332-3]
[4]
Li, G.; Zhang, L. The role of mexiletine in the management of long QT syndrome. J. Electrocardiol., 2018, 51(6), 1061-1065.
[http://dx.doi.org/10.1016/j.jelectrocard.2018.08.035] [PMID: 30497731]
[5]
Campbell, R.W. Mexiletine. N. Engl. J. Med., 1987, 316(1), 29-34.
[http://dx.doi.org/10.1056/NEJM198701013160106] [PMID: 3537793]
[6]
Monk, J.P.; Brogden, R.N. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs, 1990, 40(3), 374-411.
[http://dx.doi.org/10.2165/00003495-199040030-00005] [PMID: 2226221]
[7]
Manolis, A.S.; Deering, T.F.; Cameron, J.; Estes, N.A. III Mexiletine: pharmacology and therapeutic use. Clin. Cardiol., 1990, 13(5), 349-359.
[http://dx.doi.org/10.1002/clc.4960130509] [PMID: 2189614]
[8]
Turgeon, J.; Uprichard, A.C.G.; Bélanger, P.M.; Harron, D.W.G.; Grech-Bélanger, O. Resolution and electrophysiological effects of mexiletine enantiomers. J. Pharm. Pharmacol., 1991, 43(9), 630-635.
[http://dx.doi.org/10.1111/j.2042-7158.1991.tb03552.x] [PMID: 1685521]
[9]
Hill, R.J.; Duff, H.J.; Sheldon, R.S. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels. Mol. Pharmacol., 1988, 34(5), 659-663.
[PMID: 2848186]
[10]
De Luca, A.; Natuzzi, F.; Lentini, G.; Franchini, C.; Tortorella, V.; Conte Camerino, D. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers. Naunyn Schmiedebergs Arch. Pharmacol., 1995, 352(6), 653-661.
[http://dx.doi.org/10.1007/BF00171325] [PMID: 9053738]
[11]
Franchini, C.; Carocci, A.; Catalano, A.; Cavalluzzi, M.M.; Corbo, F.; Lentini, G.; Scilimati, A.; Tortorella, P.; Camerino, D.C.; De Luca, A. Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels. J. Med. Chem., 2003, 46(24), 5238-5248.
[http://dx.doi.org/10.1021/jm030865y] [PMID: 14613326]
[12]
Grech-Belanger, O.; Turgeon, J.; Gilbert, M. Stereoselective disposition of mexiletine in man. Br. J. Clin. Pharmacol., 1986, 21(5), 481-487.
[http://dx.doi.org/10.1111/j.1365-2125.1986.tb02829.x] [PMID: 3718807]
[13]
McErlane, K.M.; Igwemezie, L.; Kerr, C.R. Stereoselective serum protein binding of mexiletine enantiomers in man. Res. Commun. Chem. Pathol. Pharmacol., 1987, 56(1), 141-144.
[PMID: 3589151]
[14]
Vandamme, N.; Broly, F.; Libersa, C.; Courseau, C.; Lhermitte, M. Stereoselective hydroxylation of mexiletine in human liver microsomes: implication of P450IID6--a preliminary report. J. Cardiovasc. Pharmacol., 1993, 21(1), 77-83.
[http://dx.doi.org/10.1097/00005344-199301000-00011] [PMID: 7678683]
[15]
Catalano, A.; Budriesi, R.; Bruno, C.; Di Mola, A.; Defrenza, I.; Cavalluzzi, M.M.; Micucci, M.; Carocci, A.; Franchini, C.; Lentini, G. Searching for new antiarrhythmic agents: evaluation of meta-hydroxymexiletine enantiomers. Eur. J. Med. Chem., 2013, 65, 511-516.
[http://dx.doi.org/10.1016/j.ejmech.2013.05.008] [PMID: 23777871]
[16]
Zeitlin, A.L.U.S.U.S. Patent 97786749, Chem. Abstr. 1999, 129, 15325.
[17]
Rekoske, J.E. Chiral separations. AIChE J., 2001, 47(1), 2-5.
[http://dx.doi.org/10.1002/aic.690470102]
[18]
Catalano, A.; Carocci, A.; Sinicropi, M.S. Mexiletine metabolites: A review. Curr. Med. Chem., 2015, 22(11), 1400-1413.
[http://dx.doi.org/10.2174/0929867322666150227145412] [PMID: 25723511]
[19]
Catalano, A.; Carocci, A. Antiarrhythmic mexiletine: A review on synthetic routes to racemic and homochiral mexiletine and its enantioseparation. Curr. Med. Chem., 2016, 23(29), 3227-3244.
[http://dx.doi.org/10.2174/0929867323666160517120234] [PMID: 27183983]
[20]
Turgeon, J.; Fiset, C.; Giguère, R.; Gilbert, M.; Moerike, K.; Rouleau, J.R.; Kroemer, H.K.; Eichelbaum, M.; Grech-Bélanger, O.; Bélanger, P.M. Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man. J. Pharmacol. Exp. Ther., 1991, 259(2), 789-798.
[PMID: 1941626]
[21]
Franchini, C.; Cellucci, C.; Corbo, F.; Lentini, G.; Scilimati, A.; Tortorella, V.; Stasi, F. Stereospecific synthesis and absolute configuration of Mexiletine. Chirality, 1994, 6(7), 590-595.
[http://dx.doi.org/10.1002/chir.530060713]
[22]
Aav, R.; Parve, O.; Pehk, T.; Claesson, A.; Martin, I. Preparation of highly enantiopure stereoisomers of 1-(2, 6-dimethylphenoxy)-2-aminopropane (Mexiletine). Tetrahedron Asymmetry, 1999, 10(15), 3033-3038.
[http://dx.doi.org/10.1016/S0957-4166(99)00311-0]
[23]
González-Sabín, J.; Gotor, V.; Rebolledo, F. CAL-B-catalyzed resolution of some pharmacologically interesting β-substituted isopropylamines. Tetrahedron Asymmetry, 2002, 13(12), 1315-1320.
[http://dx.doi.org/10.1016/S0957-4166(02)00336-1]
[24]
Nechab, M.; Azzi, N.; Vanthuyne, N.; Bertrand, M.; Gastaldi, S.; Gil, G. Highly selective enzymatic kinetic resolution of primary amines at 80 degrees C. comparative study of carboxylic acids and their ethyl esters as acyl donors. J. Org. Chem., 2007, 72(18), 6918-6923.
[http://dx.doi.org/10.1021/jo071069t] [PMID: 17676806]
[25]
Koszelewski, D.; Pressnitz, D.; Clay, D.; Kroutil, W. Deracemization of mexiletine biocatalyzed by ω-transaminases. Org. Lett., 2009, 11(21), 4810-4812.
[http://dx.doi.org/10.1021/ol901834x] [PMID: 19785441]
[26]
Carocci, A.; Franchini, C.; Lentini, G.; Loiodice, F.; Tortorella, V. Facile entry to (-)-(R)- and (+)-(S)-mexiletine. Chirality, 2000, 12(3), 103-106.
[http://dx.doi.org/10.1002/(SICI)1520-636X(2000)12:3<103:AID-CHIR1>3.0.CO;2-X] [PMID: 10689287]
[27]
Cavalluzzi, M.M.; Catalano, A.; Bruno, C.; Lovece, A.; Carocci, A.; Corbo, F.; Franchini, C.; Lentini, G.; Tortorella, V. Synthesis of (R)-,(S)-, and (RS)-hydroxymethylmexiletine, one of the major metabolites of Mexiletine. Tetrahedron Asymmetry, 2007, 18(20), 2409-2417.
[http://dx.doi.org/10.1016/j.tetasy.2007.10.002]
[28]
Sasikumar, M.; Nikalje, M.D.; Muthukrishnan, M. A convenient synthesis of enantiomerically pure (R)-Mexiletine using hydrolytic kinetic resolution method. Tetrahedron Asymmetry, 2009, 20(24), 2814-2817.
[http://dx.doi.org/10.1016/j.tetasy.2009.11.014]
[29]
Loughhead, D.G.; Flippin, L.A.; Weikert, R.J. Synthesis of Mexiletine stereoisomers and related compounds via SNAr nucleophilic substitution of a Cr (CO) 3-complexed aromatic fluoride. J. Org. Chem., 1999, 64(9), 3373-3375.
[http://dx.doi.org/10.1021/jo982287c] [PMID: 11674449]
[30]
Huang, K.; Ortiz-Marciales, M.; Stepanenko, V.; De Jesús, M.; Correa, W. A practical and efficient route for the highly enantioselective synthesis of mexiletine analogues and novel β-thiophenoxy and pyridyl ethers. J. Org. Chem., 2008, 73(17), 6928-6931.
[http://dx.doi.org/10.1021/jo801181d] [PMID: 18690744]
[31]
Davis, F.A. Adventures in sulfur-nitrogen chemistry. J. Org. Chem., 2006, 71(24), 8993-9003.
[http://dx.doi.org/10.1021/jo061027p] [PMID: 17109522]
[32]
Ferreira, F.; Botuha, C.; Chemla, F.; Pérez-Luna, A. tert-Butanesulfinimines: structure, synthesis and synthetic applications. Chem. Soc. Rev., 2009, 38(4), 1162-1186.
[http://dx.doi.org/10.1039/b809772k] [PMID: 19421587]
[33]
Robak, M.T.; Herbage, M.A.; Ellman, J.A. Synthesis and applications of tert-butanesulfinamide. Chem. Rev., 2010, 110(6), 3600-3740.
[http://dx.doi.org/10.1021/cr900382t] [PMID: 20420386]
[34]
Han, S.M.; Ma, S.H.; Ha, H.J.; Lee, W.K. Nucleophilic substitution of (sulfonyloxymethyl) aziridines: an asymmetric synthesis of both isomers of Mexiletine. Tetrahedron, 2008, 64(49), 11110-11114.
[http://dx.doi.org/10.1016/j.tet.2008.09.068]
[35]
Hyun, M.H.; Han, S.C.; Lipshutz, B.H.; Shin, Y.J.; Welch, C.J. Liquid chromatographic resolution of racemic amines, amino alcohols and related compounds on a chiral crown ether stationary phase. J. Chromatogr. A, 2002, 959(1-2), 75-83.
[http://dx.doi.org/10.1016/S0021-9673(02)00431-4] [PMID: 12141563]
[36]
Lee, W.; Jin, J.Y.; Baek, C.S. Comparison of enantiomer separation on two chiral stationary phases derived from (+)-18-crown-6-2, 3, 11, 12-tetracarboxylic acid of the same chiral selector. Microchem. J., 2005, 80(2), 213-217.
[http://dx.doi.org/10.1016/j.microc.2004.07.010]
[37]
Jin, K.B.; Kim, H.E.; Hyun, M.H. Liquid chromatographic resolution of mexiletine and its analogs on crown ether-based chiral stationary phases. Chirality, 2014, 26(5), 272-278.
[http://dx.doi.org/10.1002/chir.22318] [PMID: 24677299]
[38]
Tekewe, A.; Singh, S.; Singh, M.; Mohan, U.; Banerjee, U.C. Development and validation of HPLC method for the resolution of drug intermediates: DL-3-Phenyllactic acid, DL-O-acetyl-3-phenyllactic acid and (+/-)-mexiletine acetamide enantiomers. Talanta, 2008, 75(1), 239-245.
[http://dx.doi.org/10.1016/j.talanta.2007.11.004] [PMID: 18371874]
[39]
Bhushan, R.; Dixit, S. Reversed-phase high-performance liquid chromatographic separation of diastereomers of (R,S)-mexiletine prepared by microwave irradiation with four new chiral derivatizing reagents based on trichloro-s-triazine having amino acids as chiral auxiliaries and 10 others having amino acid amides. J. Chromatogr. A, 2010, 1217(49), 7669-7676.
[http://dx.doi.org/10.1016/j.chroma.2010.09.072] [PMID: 21035811]
[40]
Bhushan, R.; Vashistha, V.K. Synthesis of variants of Marfey’s reagent having d-amino acids as chiral auxiliaries and liquid-chromatographic enantioseparation of (RS)-Mexiletine in spiked plasma: assessment and comparison with L-amino acid analogs. J. Chromatogr. A, 2015, 1379, 43-50.
[http://dx.doi.org/10.1016/j.chroma.2014.12.033] [PMID: 25576038]
[41]
Bhushan, R.; Tanwar, S. Synthesis of dinitrophenyl-L-Pro-N-hydroxysuccinimide ester and four new variants of Sanger’s reagent having chiral amines and their application for enantioresolution of mexiletine using reversed-phase high-performance liquid chromatography. J. Chromatogr. A, 2009, 1216(30), 5769-5773.
[http://dx.doi.org/10.1016/j.chroma.2009.05.086] [PMID: 19552908]
[42]
Bhushan, R.; Tanwar, S.; Dixit, S. Indirect enantioresolution of (R,S)-mexiletine by reversed-phase high-performance liquid chromatography via diastereomerization with [(S,S)-O,O′-di-p-toluoyl tartaric acid anhydride], (S)-naproxen and nine chiral reagents synthesized as variants of Marfey’s reagent. Biomed. Chromatogr., 2011, 25(3), 398-404.
[http://dx.doi.org/10.1002/bmc.1461] [PMID: 20586109]
[43]
Vashistha, V.K.; Bhushan, R. Bioanalysis and enantioseparation of dl-carnitine in human plasma by the derivatization approach. Bioanalysis, 2015, 7(19), 2477-2488.
[http://dx.doi.org/10.4155/bio.15.155] [PMID: 26457589]
[44]
Vashistha, V.K.; Bhushan, R. Chirality recognition for assessing the enantiomeric purity of Betaxolol. Tetrahedron Asymmetry, 2015, 26(5-6), 304-311.
[http://dx.doi.org/10.1016/j.tetasy.2015.01.017]
[45]
Singh, D.; Malik, P.; Bhushan, R. Superiority of thin-layer chromatography over high-performance liquid chromatography in enantioseparation. JPC-J. Planar. Chromat., 2019, 32(1), 7-12.
[http://dx.doi.org/10.1556/1006.2019.32.1.1]
[46]
Vashistha, V.K.; Martens, J.; Bhushan, R. Sensitive RP-HPLC enantioseparation of (RS)-ketamine via chiral derivatization based on (S)-levofloxacin. Chromatographia, 2017, 80(10), 1501-1508.
[http://dx.doi.org/10.1007/s10337-017-3367-2]
[47]
Alwera, S. In situ derivatization of (RS)-Mexiletine and enantioseparation using micellar liquid chromatography: A green approach. ACS Sustain. Chem.& Eng., 2018, 6(9), 11653-11661.
[http://dx.doi.org/10.1021/acssuschemeng.8b01869]
[48]
Ulu, S.T. Development of an HPLC method for the determination of mexiletine in human plasma and urine by solid-phase extraction. Talanta, 2007, 72(3), 1172-1177.
[http://dx.doi.org/10.1016/j.talanta.2007.01.008] [PMID: 19071741]
[49]
Ulu, S.T. LC Method with Precolumn Derivatization for Analysis of MEXiletine in pharmaceutical preparations. Chromatographia, 2009, 69(1-2), 39-44.
[http://dx.doi.org/10.1365/s10337-008-0897-7]
[50]
Liu, H.; Feng, F.; Ma, M.; Cui, S.; Xie, D.; Xu, S. Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2007, 858(1-2), 42-48.
[http://dx.doi.org/10.1016/j.jchromb.2007.08.004] [PMID: 17766197]
[51]
Tao, Q.F.; Zeng, S. Analysis of enantiomers of chiral phenethylamine drugs by capillary gas chromatography/mass spectrometry/flame-ionization detection and pre-column chiral derivatization. J. Biochem. Biophys. Methods, 2002, 54(1-3), 103-113.
[http://dx.doi.org/10.1016/S0165-022X(02)00134-3] [PMID: 12543494]
[52]
Vashistha, V.K.; Bhushan, R. Thin-layer chromatographic enantioseparation of atenolol and propranolol using (S)-naproxen as chiral selector: Direct and indirect approaches. J. Planar Chromatogr. Mod. TLC, 2020, 33(13), 101-107.
[http://dx.doi.org/10.1007/s00764-020-00017-0]

Rights & Permissions Print Cite
Article Metrics
49
3
© 2024 Bentham Science Publishers | Privacy Policy